Wednesday, May 30, 2012

All SharePosts Relating To "Vioxx"

Christine Miller

Christine Miller, Health Guide

(Profile)
In Remission from JRA, Active April 2006 to February 2009
Our Health Pros |  Caregiver
RSS

FDA Arthritis Advisory Committee Recommends Approval of Celebrex

On Wednesday, November 29, the Food and Drug Administration’s independent Arthritis Advisory Committee met to discuss the safety and efficacy of celecoxib, a nonsteriodal anti-inflammatory drug (COX-2 inhibitor). Celecoxib is marketed as Celebrex stuby Pfizer, Inc. The FDA approved the drug for use in adults with osteoarthritis and rheumatoid... Read moreChevron
posted 12/01/2006, comments (0)|
Read all my posts  | Subscribe
Christine Miller

Christine Miller, Health Guide

(Profile)
In Remission from JRA, Active April 2006 to February 2009
Our Health Pros |  Caregiver
RSS

Arcoxia Gets Mixed Reviews

On November 13th, the Associated Press released an article showing mixed reviews of Arcoxia, the cox-2 inhibitor drug that Merck is hoping to market as a replacement for its drug Vioxx. Merck pulled Vioxx off the market in late 2004 because of studies showing an increased risk of heart attack / cardiovascular events when taking the drug.The... Read moreChevron
posted 11/22/2006, comment (1)|
Read all my posts  | Subscribe
Christine Miller

Christine Miller, Health Guide

(Profile)
In Remission from JRA, Active April 2006 to February 2009
Our Health Pros |  Caregiver
RSS

Voixx Rulung Overturned

On August 30, a federal district judge overturned a $50 million compensatory damage award in a products liability case against Merck involving Vioxx. The judge found that the damages awarded by the jury were “grossly excessive” and ordered a new trial on the issue of damages. The judge did not overturn the findings of liability against... Read moreChevron
posted 09/08/2006, comments (0)|
Read all my posts  | Subscribe
Christine Miller

Christine Miller, Health Guide

(Profile)
In Remission from JRA, Active April 2006 to February 2009
Our Health Pros |  Caregiver
RSS

Merck Study Finds Similarities with COX-2 inhibitor & NSAID drugs

Merck, the manufacturer of Vioxx recently announced that preliminary analyses of its MEDAL (Multinational Etoricoxib and Diclofenac Arthritis Long-Term Program), show that patients with osteoarthritis and rheumatoid arthritis have similar cardiovascular outcomes between its experimental COX-2 inhibitor drug, Arcoxia, and diclofenac, a traditional... Read moreChevron
posted 09/06/2006, comments (0)|
Read all my posts  | Subscribe
Christine Miller

Christine Miller, Health Guide

(Profile)
In Remission from JRA, Active April 2006 to February 2009
Our Health Pros |  Caregiver
RSS

What Are Medications Doing to Our Bodies Long-term?

Eighteen months ago, Merck & Co. withdrew its painkiller Vioxx from the market, stating that research data showed that patients who took Vioxx for 18 months had an increased risk of heart attacks. Since then, more than 11,500 law suits have been filed against the drug manufacturer by people who claim to have had heart attacks as a result of... Read moreChevron
posted 05/19/2006, comments (0)|
Read all my posts  | Subscribe

Ask a Question

Get answers from our experts and community members.

Btn_ask_question_med
View all questions (3513) >
Related Rheumatoid Arthritis Topics